Physician profile
Laali A Ali
NPI 1396974119
$692.82
in general payments reported to CMS, 2019-2025
13 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $437 · 2023: $40.03 · 2024: $30.60 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $199.11 | 2022 | |
| Averitas Pharma INC. | $125.00 | 2025 | Qutenza |
| Lilly USA, LLC | $64.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.36 | 2022 | |
| Abbvie INC. | $41.83 | 2022 | |
| Glaxosmithkline, LLC. | $38.56 | 2022-2023 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $36.85 | 2022 | |
| Neurocrine Biosciences, INC. | $35.92 | 2025 | |
| Exact Sciences Corporation | $30.60 | 2024 | Cologuard Collection Kit |
| Ars Pharmaceuticals Operations, INC. | $24.03 | 2025 | Neffy |
| Novo Nordisk INC | $22.21 | 2022 | |
| Corium, LLC | $16.84 | 2023 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laali Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.